# Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow

> **NCT02755389** · PHASE4 · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 45 (actual)

## Conditions studied

- Apneic Oxygenation

## Interventions

- **DRUG:** 0 L/min oxygen via conventional nasal cannulae
- **DRUG:** 15 L/min oxygen via conventional nasal cannulae
- **DRUG:** 60 L/min oxygen via high-flow nasal cannulae

## Key facts

- **NCT ID:** NCT02755389
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-06-22
- **Final completion:** 2018-06-22
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02755389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02755389, "Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02755389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*